EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves’ Orbitopathy

Dayoon Cho, Soo Hyun Choi, Jin Sook Yoon, JaeSang Ko

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.5.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Dayoon Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, Nicotinamide N-Methyltransferase, Gene Expression Regulation, Enzymologic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Nicotinamide N-methyltransferase (NNMT) has been implicated in inflammatory autoimmune disease pathogenesis, although its pro-inflammatory role in Graves' orbitopathy (GO) is unclear. Therefore, we investigated the influence and mechanisms of NNMT in GO inflammation.

Methods

We evaluated NNMT mRNA expression in GO and non-GO orbital tissues via reverse transcription-quantitative PCR analysis. A pro-inflammatory process was induced in primary cultured orbital fibroblasts via interleukin (IL)-1β treatment, and NNMT expression was assessed by Western blotting. To further investigate the role of NNMT in GO inflammation, we inhibited NNMT expression and activity using small interfering RNA (siRNA) and pharmacologic antagonists, respectively. The production of inflammatory cytokines and intracellular signaling molecules were analyzed via Western blotting and enzyme-linked immunosorbent assay analysis.

Results

NNMT mRNA expression levels were higher in GO orbital tissues than in healthy orbital tissues. Tissues from patients with type Ⅱ GO showed higher NNMT expression than those with type Ⅰ GO. Pro-inflammatory stimulation induced NNMT expression in dose- and time-dependent manners. NNMT siRNA and antagonists attenuated the expression of pro-inflammatory cytokines (IL-6, IL-8, and monocyte chemotactic protein-1), cyclooxygenase-2, and prostaglandin E2 in orbital fibroblasts. NNMT silencing downregulated the active forms of intracellular signaling molecules (extracellular signal-regulated kinase, c-Jun-terminal kinase, and p38).

Conclusions

Our results demonstrate that NNMT was associated with the inflammatory mechanisms of GO. Inhibiting NNMT, either through mRNA silencing or pharmacologic antagonism, markedly reduced pro-inflammatory reactions. These findings suggest that targeting NNMT is a promising therapeutic strategy for managing inflammation in GO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves OphthalmopathyNicotinamide N-MethyltransferaseGene Expression Regulation, EnzymologicHumansCells, CulturedFibroblastsEnzyme-Linked Immunosorbent AssayBlotting, WesternRNA, MessengerMaleFemaleMiddle AgedInflammationRNA, Small InterferingCytokinesAdultOrbit

Substanzen

Nicotinamide N-MethyltransferaseRNA, MessengerRNA, Small InterferingCytokinesNNMT protein, human

Autor:innen und Institutionen

  • Department of Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Ophthalmology, Severance Hospital, The Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.

Zitieren

APA

Cho, D., Choi, S. H., Yoon, J. S., & Ko, J. (2025). Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves’ Orbitopathy. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.5.3

Vancouver

Cho D, Choi SH, Yoon JS, Ko J. Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves’ Orbitopathy. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.5.3

BibTeX
@article{Cho2025,
  author = {Cho, Dayoon and Choi, Soo Hyun and Yoon, Jin Sook and Ko, JaeSang},
  title = {Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves’ Orbitopathy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.5.3}
}
Kostenlos starten →